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A lymphocyte population may be subdivided into developmental and functional 
categories. The bone marrow-derived (B)  lymphocytes have a high concentration of 
surface immunoglobulin (Ig) 1 (1-3) and provide the precursors of antibody-secreting 
cells (4). The thymus-processed (T) lymphocytes, on the other hand, have a very low, 
if at all detectable surface Ig concentration (1.-3) and have the capability to become 
cytotoxic to target ceils bearing histocompatibility antigens against which the T cells 
have been sensitized (5, 6). It seems likely, however,  that cells other than T  cells can 
be killer cells for target cells. For example, in one system using antibody-coated target 
cells the cell-mediated lysis appears to be a non-T cell function (7, 8). 
With the development of methods for isolation of B- or T cell-deficient populations 
it has been possible to delineate the functions of these cells and some of their inter- 
relationships. Cytotoxicity studies using immune B- and T  cell-deficient populations 
have been performed within the H-2 system (5, 6)  demonstrating T  cells to be the 
dominating killer cells in these tests. With tumor-specific and/or virally determined 
antigens in syngeneic hosts,  T  vs. B or non-T cytotoxicity in vitro have not been de- 
fined. 
Using Moloney sarcoma virus  (MSV)-induced tumors in BALB/c  mice it 
has  been demonstrated  that,  from  animals in which  tumors have  regressed, 
lymphocytes are cytotoxic against cells carrying the Moloney leukemia virus 
(MLV)-determined surface  antigen (9).  In the present investigation lympho- 
cyte cytotoxicity was examined against target cells possessing the MLV surface 
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antigen,  using T-  or  B  cell-deficient  subpopulations  as  well  as unfractionated 
lymphocytes from BALB/c  regressor mice. 
Materials and Methods 
Animals.--BALB/c mice of both sexes 6 wk to 3 months of age were used as a  source of 
lymphocytes. Control animals were matched with immune animals by sex and age. 
Virus.--MSV-M (SVRP 224, prepared from the 224th passage in weanling BALB/c mice) 
was kindly provided by Dr. J. B. Moloney, National Cancer Institute, Bethesda, Md. 
Inoculatiom.--Animals  received 0.1 ml of the MSV suspension intramuscularly. Tumors 
developed between 5 and 10 days and usually regressed by day 25 with a peak tumor size of 
10-15 mm about day 15. The lymphocytes were harvested from animals 30 days after MSV 
infection, 8-10 days after tumor regression. One group of control animals received 0.1  ml of 
sheep red blood cells (SRBC) intraperitoneally 30 days before testing. 
Medium.--Minimal  essential medium (Eagle's) with 10% heat-inactivated fetal calf serum 
(FCS), 100 #g/ml penicillin, and 50 #g/ml streptomycin was used. 
Lymphocytes.--Lymph nodes from the axillary and inguinal regions and spleens dissected 
out under sterile conditions were teased apart in ice-cold medium without FCS, mixed with a 
Pasteur pipette, and passed over a fine nylon mesh filter. The cells were pelleted at 200 g for 
10  rain and  resuspended  in  tris(hydroxymethyl)aminomethane-buffered 0.75%  ammonium 
chloride, pH 7.2, and incubated for 10 rain at 37°C  to lyse erythrocytes (10). The cells were 
washed three times with medium without FCS, resuspended in complete medium, and counted 
in a  hemacytometer using the trypan blue dye exclusion technique to assess the viability. 
Preparation of Nonthymus-Processed Lymphocytes.--By using antisera with specificity for 
mouse T  cells it is possible to lyse these cells in the presence of complement, leaving viable 
cells which are predominantly B  cells  (11).  An anti-T serum produced in a  rabbit against 
mouse thymus cells and absorbed repeatedly with mouse myeloma cells and with repopulated 
spleen  cells from  thymectomized,  lethally irradiated,  bone  marrow-protected  animals has 
been described previously (6,  11). Spleen cells remaining after treatment with this antiserum 
are  enhanced  in  their capability  to  respond  to  a  thymus-independent antigen,  but  their 
ability to respond to a  thymus-dependent antigen is decreased by more than 90%  (6,  11). 
This antiserum in the presence of complement will completely abolish the capability of T 
cells to be cytotoxic in anti-H-2 tests (6). 
In the present experiments,  1-2  )<  107 immune or control lymphocytes were incubated 
with 1 ml of a 1:100 dilution of the anti-T serum for 30 rain at 4°C, after which normal rabbit 
serum at a  final concentration of 1:20 was added as a  source of complement and incubated 
for 30 rain at 37°C. The anti-T serum has an activity against thymus-derived cells at dilutions 
as high as 1 : 10,000 but no activity against bone marrow-repopulated spleen cells at dilutions 
higher than 1:10 (6,  11).  After determination of viability by trypan blue dye exclusion, the 
cells were pelleted by centrifugation at 600 g and suspended in 1.5 ml of 0.25% trypsin. After 
incubation for 10 rain at 37°C, the trypsin was neutralized by addition of medium with FCS 
and the cell suspension was passed over a  nylon mesh filter to remove aggregates of debris 
forming from the trypsinized dead cells. The cells were then washed twice with medium before 
use. This procedure removes ahnost all dead cells leaving a 95-100% viable non-T cell popula- 
tion. The trypsin treatment and washing should also remove any possible anti-T antibodies 
attached to the remaining cells. 
In one experiment the cell population thus prepared was passed through a  5 cm cotton 
wool column prepared in a  Pasteur pipette prewashed with medium at  room temperature. 
In  parallel,  control lymphocytes from  animals which had  been immunized against  SRBC 
were also passed through a  cotton wool column of the same size and conditions. This pro- 
cedure should reduce the number of macrophages  (12)  and mature antibody-secreting cells 1074  SPECIFIC  TUMOR  CELL  CYTOTOXICITY  BY  A  NON-T  CELL 
(13).  5  X  10  ~ of these cells immune to SRBC were tested for 7S  hemolytic plaque-forming 
cells (14)  in duplicate plates before and after passage over cotton wool. 
Preparation of T Cells.--By filtering the lymphocytes through glass bead columns, coated 
first with mouse Ig and then with rabbit anti-mouse Ig in excess, it is possible to trap cells 
with a  high concentration of membrane-bound Ig, i.e., B  cells. Thus, the eluted cell popula- 
tion will be primarily T  cells (ll). Lymphocyte populations passed over such a  column have 
been demonstrated to be predominantly T  cells by multiple criteria (6, 11). In the H-2 system, 
immune  cells passed  across  such  columns  have  an  increased  cytotoxicity  against  the  ap- 
propriate target cells (6). In the present experiments, an aliquot of the cells eluted from the 
column were treated with anti-T serum and complement as described above. 85-95% of this 
subpopulation of cells were killed  by this treatment as compared with approximately  50% 
cytotoxicity of the unfractionated  mixture of spleen and  lymph node cells. Samples of 2-5 
X  107 unfractionated lymphocytes from control or immune animals were fractionated by the 
use of these anti-Ig-coated columns as previously described (6, 11). The number of cells eluted 
from the columns was 20-30%  of the original number. After elution the cells were pelleted 
by centrifugation, resuspended in complete medium, and counted in a hemacytometer. 
Target Cdls.--The following cell lines were used:  (a)  Ha2 cells, a  line established from an 
MSV-induced tumor of a  CBA mouse. These cells produce both MSV and MLV and possess 
the MLV-determined surface antigen (15).  (b) D56 cells, a mixture of S+L  -  (sarcoma-positive, 
leukemia-negative) cells and normal 3T3  cells from  NIH  Swiss  embryo  fibroblast cultures 
(provided through the courtesy of Dr. R. H. Bassin, NIH, Bethesda, Md.)  S+L  -  cells were 
isolated by appropriate selection procedures from MSV-transformed 3T3 cells (16). The cells 
contain  the MSV genome but  do not produce infectious virus nor do they possess a  viral- 
associated surface antigen which would distinguish them from normal 3T3  cells  (9).  These 
cells are not killed  by MSV immune lymphocytes (9).  (e) D56-M  cells, MLV superinfected 
D56  cells. The latter two lines are identical except for infectious virus production and  the 
presence of the MLV-associated surface antigen in the D56-M line, which has also been shown 
to be killed by MSV immune lymphocytes (9). 
Determination  of Lymphocyte  Cytotoxicity.--The  microcytotoxicity  method  of  Takasugi 
and Klein  (17)  was used. 50-100  target cells were seeded into each well of microplates (No. 
3034;  Falcon Plastics, Div. B-D Laboratories Inc., Los Angeles, Calif.)  and incubated over- 
night at 37°C in 5% CO2. The lymphocytes were added to the target cells in ratios of 200:1, 
100:1,  50: 1,  and  25:1.  Control and immune lymphocytes were always tested  on the same 
plate using six replicates for each lymphocyte dilution and  12  replicate wells containing no 
lymphocytes (blank control). After incubation for 48 hr, medium was removed and the plates 
were washed once with balanced salt solution to remove dead cells. The plates were fixed with 
methanol and stained with eosin methylene blue and Giemsa, and the target cells remaining 
in each well were counted  (hereafter reference to well indicates the number of target cells in 
the well).  The  arithmetic  mean  and  standard  deviation  of the  six  replicate  wells of each 
lymphocyte dilution was determined and a  Student's t test was performed to assess the sig- 
nificance of the differences between wells containing immune ]ymphocytes and  those con- 
taining the same number of control lymphocytes. A significant difference between control and 
immune wells was considered to exist when the P  value was less than 0.05. The relative per- 
centage  of remaining  target  cells in wells containing  immune  lymphocytes was  calculated 
compared with the wells containing the same number of control lymphocytes. Control and 
immune  lymphocytes and  their  fractionated  subpopulations  from  individual  animals were 
tested in three separate experiments. 
RESULTS 
Table I  shows the results of the experiments using Ha2 target ceils. There 
was significant killing (P less than 0.05) by the unfractionated lymphocytes in E.  W.  LAMON~  It.  M.  SKURZAK~  E.  KLEIN~  H.  WIGZELL  1075 
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experiments 2 and 3. In all three experiments the killing was increased by ren- 
dering the population deficient of T  cells.  The relatively pure T  cell subpopu- 
lations,  however, eluted from  the  columns in  experiments 2  and  3  were less 
cytotoxic to the target cells than the comparable unfractionated lymphocytes. 
The 200:1  lymphocyte to target cell ratio in experiment 2 showed significant 
cytotoxicity by the immune T  cells, but this was not found at lower ratios. 
Donors  of  control  cells  in  experiment  3  were  immunized  against  SRBC. 
These lymphocytes produced no killing of the target cells compared with the 
blank control. In the same experiment MSV immune lymphocytes produced 
significant killing using unfractionated or non-T cell populations, whereas the 
immune T cells had no significant cytotoxic activity at any ratio. 
The non-T cell killing was  demonstrated to be specific for the MLV-asso- 
ciated cell surface antigen by testing against D56 (MLV-negative) and D56-M 
(MLV-positive) target cells. Table II shows the effects of the non-T cell popu- 
lation from experiment 2 on these lines. There is significant killing by the im- 
mune cells of the D56-M  line,  whereas  the  immune  ceils have no  cytotoxic 
effect on the D56 line. 
Thus, this killing is specific for the MLV-determined cell surface antigen by 
the following criteria:  (a)  the MSV immune non-T lymphocytes significantly 
reduce the number of surviving target cells (Ha2 and D56-M) compared with 
control non-T lymphocytes from unimmunized animals,  (b) the immune lym- 
phocytes kill only those target cells which possess the MLV-associated surface 
antigen  (Ha2  and D56-M)  but not cells which  are MLV antigen free (D56), 
(c) immunization with a nonpertinent antigen (SRBC) produces no killing of 
the Ha2 target cells. 
In  order  to  decrease  the  number  of  macrophages  and  mature  antibody- 
secreting cells,  the MSV immune and SRBC immune T  cell-deficient prepara- 
tions were passed over identical cotton wool columns. An aliquot of the SRBC 
immune cells was tested for SRBC hemolytic plaque-forming cells before and 
after passage.  This procedure decreased  the  number  of plaque-forming cells 
per 5 X  10  ~ cells by one-third. There was no significant difference in the ability 
to kill the Ha2 target cells by the MSV immune non-T cells before or after the 
cotton wool column (Table I,  experiments 3a and  3b,  respectively)  as deter- 
mined by a Student's t test between the wells containing immune lymphocytes 
on each plate. 
DISCUSSION 
Lymphocytes from BALB/c mice  30  days  after  MSV  infection and  8-10 
days after tumor regression are cytotoxic in vitro against target cells bearing 
the MLV-determined surface antigen.  Fractionation of these lymphocytes at 
this  time  shows  the  most  active cell to be  a  nonthymus-processed cell.  The 
killer cell in this system could conceivably be a non-B cell,  however, there is 
some evidence in favor of a B cell as at least one type of killer cell in this sys- E.  W.  LAMON,  H.  M.  SKURZAK,  E.  KLEIN,  H.  WIGZELL  1077 
tem.  First,  killing  ceils  were  excluded  from  the  lymphocyte population  by 
passage over an anti-Ig-coated glass bead column, suggesting a high Ig surface 
concentration on the active cell population, however, Fc binding receptors on 
cells other than B  lymphocytes (18-20)  could also be involved. Secondly, no 
significant decrease in killing was observed after passage of this subpopulation 
over a cotton wool column, which should remove or decrease the percentage of 
macrophages (12). 
The mechanism of killing by this non-T subpopulation of cells is unknown. 
If B  lymphocytes are indeed responsible for this killing, membrane-bound Ig 
on the cell of production in such a  system could activate the cell to lyse the 
target  cell  by  unknown  mechanisms  after  the  antibody  allowed  the  killer- 
target contact (21). On the other hand, if antibody is secreted by the immune 
cells,  this could bind to the target cells and bring about cytotoxicity through 
the receptor for antigen-antibody complexes on normal B cells (11,  20, 22, 23) 
and macrophages (19).  Such a phenomenon has been demonstrated to exist in 
several systems (7, 8, 24, 25) including the MSV rat system where target cells 
pretreated with high concentrations of antisera were lysed by the lymph node 
cells (26). 
Preliminary evidence from time-course studies  in  this  laboratory indicate 
that T  cells also function as killer cells in the present system, but primarily at 
times closer to  tumor development and  regression. The present results show 
the predominant subpopulation of active cells 30 days after MSV infection to 
be a non-T cell in three separate experiments. 
In summary, it appears in this system that tumor cell destruction by lymph- 
oid cells may to  a  significant extent be mediated by a  nonthymus-processed 
subpopulation (possibly B cells).  This would seem to be in contrast to the cell- 
mediated lysis in  the transplantation  systems involving major histocompati- 
bility antigens where T  cells are reported to be the most significant mediators 
of target cell destruction (5, 6). 
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